Deutsche Bank
DGX icon

Deutsche Bank’s Quest Diagnostics DGX Stock Holding History

Deutsche Bank’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-40
Closed -$5K – 4166
2022
Q1 		$5K Buy
+40
New +$5.58K ﹤0.01% 4161

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Deutsche Bank's DGX Position: Q2 2026 in Review

Deutsche Bank increased its Quest Diagnostics (DGX) stake by 6.4% in Q2 2026, buying an estimated $6.87M and bringing the position to 585,895 shares worth $124M. The position accounts for 0.04% of the portfolio, ranked #435.

Deutsche Bank first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $142M in Q1 2015. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Deutsche Bank held 585,895 shares of Quest Diagnostics worth $124M as of Q2 2026.
  • Deutsche Bank bought 34,996 Quest Diagnostics shares in Q2 2026, an estimated $6.87M.
  • Quest Diagnostics made up 0.04% of Deutsche Bank's portfolio in Q2 2026, its #435 holding.
  • Deutsche Bank first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Quest Diagnostics position peaked at $142M in Q1 2015.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.